International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

S Wheelwright, A-S Darlington, D Fitzsimmons, P Fayers, J I Arraras, F Bonnetain, E Brain, A Bredart, W-C Chie, J Giesinger, E Hammerlid, S J O'Connor, S Oerlemans, A Pallis, M Reed, N Singhal, V Vassiliou, T Young, C Johnson, S Wheelwright, A-S Darlington, D Fitzsimmons, P Fayers, J I Arraras, F Bonnetain, E Brain, A Bredart, W-C Chie, J Giesinger, E Hammerlid, S J O'Connor, S Oerlemans, A Pallis, M Reed, N Singhal, V Vassiliou, T Young, C Johnson

Abstract

Background: Older people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC's core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged >70 years in oncology studies.

Methods: Patients (n=518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test-retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA).

Results: Information from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test-retest and RCA analyses were equivocal.

Conclusion: The QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged 70 years. Changes in elderly patients' self-reported HRQOL may be related to both cancer evolution and non-clinical events.

References

    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
    1. Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, Soubeyran PL. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23:2166–2172.
    1. Bowling A. The psychometric properties of the Older People's Quality of Life Questionnaire, compared with the CASP-19 and the WHOQOL-OLD. Curr Gerontol Geriatr Res. 2009;2009:298950.
    1. Bowling A. Do older and younger people differ in their reported well-being? A national survey of adults in Britain. Fam Pract. 2011;28:145–155.
    1. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
    1. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A.2001EORTC QLQ-C30 Scoring Manual, Brussels, European Organisation for Research and Treatment of Cancer.
    1. Fayers P, Machin D. Quality of Life: the Assessment, Analysis and Interpretation of Patient-reported Outcomes. John Wiley & Sons: Chichester, UK; 2007.
    1. Fitzsimmons D, Gilbert J, Howse F, Young T, Arrarras J, Bredart A, Hawker S, George S, Aapro M, Johnson C. A systematic review of the use and validation of health-related quality of life instruments in older cancer patients. Eur J Cancer. 2009;45:19–32.
    1. Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why. Qual Life Res. 2009;18:115–123.
    1. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3) Eur J Cancer. 1998;34:1381–1389.
    1. Johnson C, Fitzsimmons D, Gilbert J, Arrarras JI, Hammerlid E, Bredart A, Ozmen M, Dilektasli E, Coolbrandt A, Kenis C, Young T, Chow E, Venkitaraman R, Howse F, George S, O'connor S, Yadegarfar G, Grp EQL. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15. Eur J Cancer. 2010;46:2242–2252.
    1. Johnson CD, Aaronson NK, Blazeby J, Bottomley A, Fayers P, Koeller M, Kulis D, Ramage J, Sprangers MA, Velkova G, Young T, EORTC Quality of Life Group 2011. Guidelines for developing questionnaire modules. Available at .
    1. Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P, Johnson C, Ramage J, Scott N, West K. Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer. 2007;43:1810–1820.
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186.
    1. Lichtman SM. Clinical trial design in older adults with cancer—the need for new paradigms. J Geriatr Oncol. 2012;3:368–375.
    1. Lichtman SM, Balducci L, Aapro M. Geriatric oncology: a field coming of age. J Clin Oncol. 2007;25:1821–1823.
    1. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population. Acta Oncol. 2000;39:477–484.
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.
    1. Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol. 2012;30:2036–2038.
    1. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37:1345–1351.
    1. Wedding U, Pientka L, Hoffken K. Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer. 2007;43:2203–2210.
    1. Wildiers H, Brain E, Penninckx B, Ring A, Repetto L, Soubeyran P, Monfardini S, Aapro M, Wedding U. The EORTC Cancer in the Elderly Task Force, a Protostar for EORTC's future. Eur J Cancer Suppl. 2012;10:34–38.
    1. Wright P, Smith A, Booth L, Winterbottom A, Kiely M, Velikova G, Selby P. Psychosocial difficulties, deprivation and cancer: three questionnaire studies involving 609 cancer patients. Br J Cancer. 2005;93:622–626.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe